Serdemetan (JNJ-26854165) is a potent anticancer agent with radiosensitizing activity. Serdemetan exhibits antiproliferative activity in various p53 wild-type tumor cells. Serdemetan also antagonizes the Mdm2-HIF1alpha axis leading to decreased levels of glycolytic enzymes[1][2][3].
Molekulargewicht:
328.41
Reinheit:
99.56
CAS Nummer:
[881202-45-5]
Formel:
C21H20N4
Target-Kategorie:
Apoptosis,E1/E2/E3 Enzyme,MDM-2/p53
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten